WEATHER UPDATE FEBRUARY 20. 2019

Rockville Office - Opening at 11am

Brandywine, Clinton, Lanham, Mt.Airy Offices Closed

Frederick Office Opening at 10am

 

 

 

USOR 17165

Phase 1b/2 Study to Evaluate Safety,Efficacy, Pharmacokinetics and Pharmacodnamics of Erdafitinib plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects with Metastatic or Surgically Unresectable Urothelial Cancer with Selected FGFR Gene Alterations

Disease Types

Urothelial Cancer

Available at

Rockville

Contact

Linda Iovanni
MOHRSCH@usoncology.com